U.S. markets open in 3 hours 10 minutes
  • S&P Futures

    4,464.50
    -9.75 (-0.22%)
     
  • Dow Futures

    34,680.00
    -69.00 (-0.20%)
     
  • Nasdaq Futures

    15,493.50
    -24.25 (-0.16%)
     
  • Russell 2000 Futures

    2,225.50
    -7.70 (-0.34%)
     
  • Crude Oil

    71.98
    -0.63 (-0.87%)
     
  • Gold

    1,765.50
    +8.80 (+0.50%)
     
  • Silver

    23.08
    +0.29 (+1.28%)
     
  • EUR/USD

    1.1784
    +0.0012 (+0.11%)
     
  • 10-Yr Bond

    1.3310
    0.0000 (0.00%)
     
  • Vix

    19.20
    +1.02 (+5.61%)
     
  • GBP/USD

    1.3780
    -0.0016 (-0.12%)
     
  • USD/JPY

    109.9900
    +0.2720 (+0.25%)
     
  • BTC-USD

    47,711.24
    -211.47 (-0.44%)
     
  • CMC Crypto 200

    1,216.18
    -17.11 (-1.39%)
     
  • FTSE 100

    7,021.35
    -6.13 (-0.09%)
     
  • Nikkei 225

    30,500.05
    +176.71 (+0.58%)
     

A Look at Teva’s Earnings Estimates ahead of Q2 Results

A Look at Teva’s Earnings Estimates ahead of Q2 Results
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Teva Pharmaceutical Industries (TEVA) is set to announce its Q2 2018 earnings results on August 2. Teva is expected to perform better amid the company’s restructuring plans, lower-than-expected Copaxone market share, and sales losses due to competition and reducing debt burden.